Large-scale testing (Phase 3)Ended earlyNCT04377620
What this trial is testing
Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)
Who this might be right for
COVID-19
Incyte Corporation 211